Emerging Markets 新兴市场经济与投资,逐国深度研究
← 返回India
IN

Sun Pharmaceutical Industries Limited

SUNPHARMA · National Stock Exchange of India (NSE) · Pharmaceuticals

公司简介

Sun Pharmaceutical Industries is India's largest pharmaceutical company and one of the largest generic drug manufacturers globally, with a major presence in the US, India, and emerging markets. The company produces specialty, generic, and over-the-counter medicines across a broad range of therapeutic categories. It completed a transformative acquisition of Ranbaxy Laboratories in 2015.

交易所National Stock Exchange of India (NSE)
股票代码SUNPHARMA
行业Pharmaceuticals
参考市值 美元$47.00B
网站访问官网

实时报价

正在加载实时价格……

购买渠道

在其本地市场(National Stock Exchange of India (NSE)),可通过以下提供该交易所准入的全球券商进行投资:

仅为准入信息参考,不构成推荐或购买要约。请向您的券商确认资格、费用及当前可用性。

India的其他公司

Reliance Industries Limited$198.00BHDFC Bank Limited$143.00BBharti Airtel Limited$138.00BICICI Bank Limited$115.00BState Bank of India$114.00BTata Consultancy Services Limited$82.00BBajaj Finance Limited$75.00BLarsen & Toubro Limited$57.00B

公司数据及任何实时价格均为参考性质,可能存在延迟或不准确,仅供研究参考,不构成投资建议。请以交易所、公司公告及您的券商信息为准。

主题